Home » Authors » Karen Young

Articles by Karen Young

Hyseq Raises $15M Privately To Develop Proprietary Drugs

April 10, 2002

InterMune Licenses Rights To Phase II Candidate For Fibrosis

April 9, 2002

InterMune Inc. licensed worldwide rights to develop and commercialize pirfenidone for all fibrotic diseases, including renal, liver and pulmonary fibrosis a drug candidate that plays right into the company’s field of expertise. (BioWorld Today)

Mojave Presents First Human Data From Antigen Delivery System

April 9, 2002

Mojave Presents First Human Data From Antigen Delivery System

April 9, 2002

InterMune Licenses Rights To Phase II Candidate For Fibrosis

April 9, 2002

InterMune Inc. licensed worldwide rights to develop and commercialize pirfenidone for all fibrotic diseases, including renal, liver and pulmonary fibrosis a drug candidate that plays right into the company’s field of expertise. (BioWorld Today)

Allos Charting Oncology Path, In-Licenses Cancer Product

April 8, 2002

Allos Charting Oncology Path, In-Licenses Cancer Product

April 8, 2002

GenPhar Reveals Platform, Has Partnerships With Army, NIH

April 5, 2002

LifeTime Acquires Cancer Product From Dovetail For Equity Position

April 5, 2002

LifeTime Acquires Cancer Product From Dovetail For Equity Position

April 5, 2002

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...